Patent Assignment
Reel/Frame 054123/0957
Release of Security Interest
Recorded: 2020-10-21
Pages: 6
Assignor
MIDCAP FINANCIAL TRUST
Executed: 2020-10-15
Assignee
EVOLVE BIOLOGICS INC.
420 AMBASSADOR DRIVE, MISSISSAUGA, ONTARIO, L5T 2J3, CANADA
Covered Properties
(2)
Hemoglobin-Targeted Drug Delivery For The Treatment of Cancer
Application:
16/310,197 →
Publication:
US 2023/0190947
Method for Purification of Albumin
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 8, 2019
From: BROOKES, STEVEN; ADAMSON, J. GORDON; BELL, DAVID
To: THERAPURE BIOPHARMA INC.
Reel/Frame 048539/0724 →
Assignment of Assignor's Interest
Sep 10, 2019
From: SEO, JIN SEOG; MILLER, DAVID
To: THERAPURE BIOPHARMA INC.
Reel/Frame 050327/0328 →
Intellectual Property Security Agreement
Oct 22, 2019
From: THERAPURE BIOPHARMA INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 050797/0377 →
Confirmatory Intellectual Property Assignment
Oct 23, 2019
From: THERAPURE BIOPHARMA, INC.
To: EVOLVE BIOLOGICS INC.
Reel/Frame 050798/0522 →
Security Interest
May 31, 2023
From: EVOLVE BIOLOGICS INC.; TBI PHARMA HOLDINGS LTD.
To: MONROE CAPITAL MANAGEMENT ADVISORS, LLC
Reel/Frame 063817/0151 →